Prosthesis‐Patient Mismatch in All‐Comer Patients Undergoing Newer‐Generation Self‐Expanding Transcatheter Aortic Valve Replacement
Catheterization and Cardiovascular Interventions · 2026
DOI: 10.1002/ccd.70698 ↗At a glance
Journal article in Catheterization and Cardiovascular Interventions, 2026. Written by Xander Jacquemyn and 8 co-authors. Institution: UPMC Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. Major MEDLINE topics: Heart Valve Prosthesis, Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement, Aortic Valve. 30 references. The full text is freely available in PubMed Central.
Abstract (original language)
Background
Prosthesis‐patient mismatch (PPM) after transcatheter aortic valve replacement (TAVR) may affect outcomes, but its incidence and impact with contemporary self‐expanding valves remain unclear.
Aims
Evaluate the frequency, predictors, and long‐term outcomes of PPM in a real‐world TAVR population.
Methods
We analyzed patients ≥ 18 years undergoing TAVR with current‐generation self‐expanding valves (Evolut FX/FX+, PRO/PRO+, Navitor, Navitor Vision) from a prospectively maintained institutional database (2017–2025). Predicted PPM was defined according to VARC‐3 criteria, with all‐cause mortality and heart failure hospitalization as the primary outcomes.
Results
Among 2989 patients (median age 80 [75−85], 50.8% female) receiving Evolut (83.3%) or Navitor (16.7%) valves, PPM occurred in 5.0% (moderate 3.7%, severe 1.3%) and declined from 6.5% in 2017 to 2.7% in 2025 ( p = 0.002). Independent predictors of PPM included female sex (OR 2.04, 95% CI 1.06−3.99, p = 0.035) and valve‐in‐valve procedures (OR 9.60, 95% CI 3.82−25.64, p < 0.001), whereas use of the Navitor valve was associated with markedly lower odds (OR 0.07, 95% CI 0.00−0.32, p = 0.009). Patients with PPM demonstrated significantly higher post‐procedural transvalvular gradients and reduced aortic valve areas (both p < 0.001). PPM was not associated with adverse long‐term clinical outcomes, with no significant differences in 5‐year all‐cause mortality (HR 0.84, 95% CI 0.45−1.57, p = 0.592) or heart failure hospitalization (HR 1.22, 95% CI 0.84−1.77, p = 0.295).
Conclusion
In this contemporary TAVR cohort, PPM was infrequent, and its incidence declined over time. Female sex and valve‐in‐valve procedures independently predicted PPM. Despite adverse hemodynamic profiles, PPM was not associated with early or long‐term adverse clinical outcomes.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- UPMC Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
- Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
ORCID profiles: Xander Jacquemyn, Takuya Ogami, Catalin Toma
Cite
APA
Jacquemyn, X., Ogami, T., Hasan, I., Kliner, D., Serna-Gallegos, D., Toma, C., Makani, A., West, D., & Sultan, I. (2026). Prosthesis‐Patient Mismatch in All‐Comer Patients Undergoing Newer‐Generation Self‐Expanding Transcatheter Aortic Valve Replacement. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70698
Vancouver
Jacquemyn X, Ogami T, Hasan I, Kliner D, Serna-Gallegos D, Toma C, et al. Prosthesis‐Patient Mismatch in All‐Comer Patients Undergoing Newer‐Generation Self‐Expanding Transcatheter Aortic Valve Replacement. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70698
BibTeX
@article{Jacquemyn2026,
author = {Jacquemyn, Xander and Ogami, Takuya and Hasan, Irsa and Kliner, Dustin and Serna-Gallegos, Derek and Toma, Catalin and Makani, Amber and West, David and Sultan, Ibrahim},
title = {Prosthesis‐Patient Mismatch in All‐Comer Patients Undergoing Newer‐Generation Self‐Expanding Transcatheter Aortic Valve Replacement},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
doi = {10.1002/ccd.70698}
}
EUVIMED